الرياض، المملكة العربية السعودية, 7 سبتمبر / أيلول 2022 /PRNewswire/ — أصدرت منظمة التعاون الرقمي اليوم العدد الأول من تقرير الازدهار الرقمي، لتسليط الضوء على بعض القضايا الأكثر إلحاحاً لتنمية الاقتصاد الرقمي، ومبادرات وبرامج منظمة التعاون الرقمي التي تدعم الدول الأعضاء في المنظمة لتطوير اقتصادها الرقمي.  ويهدف تقرير الازدهار الرقمي إلى تبادل أخر التحديثات حول أحدث أنشطة منظمة التعاون الرقمي، […]

Read More

VADUZ, Liechtenstein, Sept. 7, 2022 /PRNewswire/ — This Wednesday, September 7th 2022, the Liechtenstein NationalMuseum opens CUSP, a mini retrospective presenting a selection of works by Bahraini artist Rashid Al Khalifa, from atmospheric landscape paintings that mark the beginning of his artistic career in the 1970s, to his latest robust aluminium and steel installations. The exhibition […]

Read More

Real-Time Dark Web Intelligence Empowers Financial Institutions, Card Issuers, and E-commerce Providers to Prevent Payment Fraud BOSTON, Sept. 7, 2022 /PRNewswire/ — Recorded Future, the world’s largest intelligence company, today announced the expansion of its Intelligence Cloud with Payment Fraud Intelligence, a single source of truth for identifying, mitigating, and preventing payment fraud. Payment Fraud Intelligence enables those focused […]

Read More

PRINCETON, N.J., Sept. 7, 2022 /PRNewswire/ — Miami International Holdings, Inc. (MIH) today reported August 2022 trading results for its U.S. exchange subsidiaries – MIAX®, MIAX Pearl® and MIAX Emerald® (together, the MIAX Exchange Group™), and Minneapolis Grain Exchange (MGEX™). August 2022 Trading Volume Highlights Total U.S. multi-listed options market share for the MIAX Exchange […]

Read More

WALTHAM, Mass. et SHANGHAI, Chine, 07 sept. 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, une société biopharmaceutique mondiale déterminée à devenir un leader dans le développement et la commercialisation de thérapies immunitaires pour les patients dans le besoin à travers le monde, a annoncé aujourd’hui la nomination de Simon Lowry, M.D., au poste de directeur médical […]

Read More

WALTHAM, Mass. and SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the appointment of Simon Lowry, M.D., as the company’s Chief Medical Officer. Dr. Lowry brings over […]

Read More